You are here

Article info

Article menu
Download PDFPDF
Basic and translational research
Extended report
Simvastatin inhibits the pro-inflammatory and pro-thrombotic effects of IL-17 and TNF-α on endothelial cells

Authors

  • Arnaud Hot Department of Immunology and Rheumatology and the Immunogenomics and inflammation, Hospices Civils de Lyon, University of Lyon 1 mixed research unit, Hospital Edouard Herriot, Lyon, France PubMed articlesGoogle scholar articles
  • Fabien Lavocat Department of Immunology and Rheumatology and the Immunogenomics and inflammation, Hospices Civils de Lyon, University of Lyon 1 mixed research unit, Hospital Edouard Herriot, Lyon, France PubMed articlesGoogle scholar articles
  • Vanina Lenief Department of Immunology and Rheumatology and the Immunogenomics and inflammation, Hospices Civils de Lyon, University of Lyon 1 mixed research unit, Hospital Edouard Herriot, Lyon, France PubMed articlesGoogle scholar articles
  • Pierre Miossec Department of Immunology and Rheumatology and the Immunogenomics and inflammation, Hospices Civils de Lyon, University of Lyon 1 mixed research unit, Hospital Edouard Herriot, Lyon, France PubMed articlesGoogle scholar articles
  1. Correspondence to Professor Pierre Miossec, Clinical Immunology and Rheumatology Unit, Hospices Civils de Lyon, University of Lyon 1 mixed research unit, EA 4130, Hospital Edouard Herriot, 69437 Lyon Cedex 03, France; pierre.miossec{at}univ-lyon1.fr
View Full Text

Citation

Hot A, Lavocat F, Lenief V, et al
Simvastatin inhibits the pro-inflammatory and pro-thrombotic effects of IL-17 and TNF-α on endothelial cells
Annals of the Rheumatic Diseases 2013;72:754-760.

Publication history

  • Accepted July 20, 2012
  • First published August 21, 2012.
Online issue publication 
September 13, 2020

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions